Intraperitoneal injections of copper ferrite nanoparticles disturb blood, plasma, and antioxidant parameters of Wistar rats in a sex-specific manner

• Published in: Naunyn-Schmiedeberg's archives of pharmacology 2020-11, Vol.393 (11), p.2019-2028
• Main Authors: Riaz, Hasna, Hashmi, Rimsha, Abid, Shairyar, Shareef, Nisha, Faqir, Abida, Amir, Aqsa, Shahzad, Muhammad Saqib, Shakeel, Muhammad, Akhtar, Saeed, Ashiq, Muhammad Naeem, Ibrahim, Ather, Iqbal, Furhan
• Format: Article
• Language: English
• Subjects: Antioxidants; Biocompatibility; Biomedical and Life Sciences; Biomedicine; Blood; Blood platelets; Body weight; Catalase; Copper; Kidneys; Liver; Malondialdehyde; Nanoparticles; Neurosciences; Original Article; Pattern recognition; Pharmacology/Toxicology; Plasma; Platelets; Rodents; Scanning electron microscopy; Superoxide dismutase; X-ray diffraction
• ISSN: 0028-1298; 1432-1912
• DOI: 10.1007/s00210-020-01899-x

The present study was designed to report the synthesis and characterization of copper ferrite nanoparticles (CF NPs) and their biocompatibility in Wistar rats. Coprecipitation method was used to generate CF NPs having average diameter of 14.06 nm. NPs were characterized by scanning electron microscopy and X-ray diffraction. Six-week-old Wistar rats of both sexes intraperitoneally received 10 mg/ml saline/Kg body weight of CF NPs for 14 days. Control groups were maintained in parallel that received saline solution for 14 days through same route. Open field and novel object recognition tests, complete blood count, selected plasma parameters, antioxidants, and copper concentration in vital organs were determined in all treatments. Female rats treated with CF NPs had significantly higher platelet count ( P = 0.05) and platelet crit ( P = 0.05) and decreased plasma triglyceride concentration levels ( P = 0.02) than control group. Female rats had significantly increased levels of superoxide dismutase ( P = 0.01), catalase ( P = 0.05), and malonaldehyde ( P = 0.05) in the kidney, while male rats had significantly elevated levels of superoxide dismutase in the lungs ( P = 0.01) as compared with respective control groups. Copper concentrations in the liver were significantly higher in both female ( P = 0.04) and male ( P = 0.05) rats exposed to CF NPs than control group. All other studied parameters of behavioral tests, blood biochemistry, antioxidant, and copper concentrations in the brain varied nonsignificantly ( P > 0.05) when compared between CF NPs treated and untreated rats of both sexes. Intraperitoneal supplementation of CF NPs for 14 days disturbed the platelet count, plasma triglyceride concentration, copper levels in the liver, and antioxidant concentrations in the kidney of female Wistar rats. These parameters remained unaffected in male subjects.